It indicates that IL-6 may also regulate the process of EMT during the progression of NSCLC, by which cells change from a highly polarized epithelial phenotype with intact cell–cell junctions to a migratory mesenchymal phenotype to promote tumor cell metastasis (Sullivan et al. 2009). The gene discussed is IL6; the disease is non-small cell lung carcinoma.